Hepion Total Current Assets from 2010 to 2024

HEPA Stock  USD 1.26  0.02  1.61%   
Hepion Pharmaceuticals' Total Current Assets are increasing over the years with slightly volatile fluctuation. Overall, Total Current Assets are expected to go to about 24 M this year. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2013-09-30
Previous Quarter
17.5 M
Current Value
17.5 M
Quarterly Volatility
34.5 M
 
Yuan Drop
 
Covid
Check Hepion Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hepion main balance sheet or income statement drivers, such as Depreciation And Amortization of 81.3 K, Selling General Administrative of 6.5 M or Other Operating Expenses of 47.5 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.86. Hepion financial statements analysis is a perfect complement when working with Hepion Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Hepion Pharmaceuticals Technical models . Check out the analysis of Hepion Pharmaceuticals Correlation against competitors.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.

Latest Hepion Pharmaceuticals' Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Hepion Pharmaceuticals over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Hepion Pharmaceuticals' Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hepion Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Hepion Total Current Assets Regression Statistics

Arithmetic Mean19,065,516
Geometric Mean4,480,544
Coefficient Of Variation143.12
Mean Deviation19,242,577
Median7,894,985
Standard Deviation27,285,957
Sample Variance744.5T
Range97.4M
R-Value0.63
Mean Square Error486.7T
R-Squared0.39
Significance0.01
Slope3,825,134
Total Sum of Squares10423.3T

Hepion Total Current Assets History

202424 M
202317.5 M
202256.5 M
202197.5 M
202042.6 M
201914.4 M
2018M

About Hepion Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Hepion Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Hepion Pharmaceuticals investors use historical funamental indicators, such as Hepion Pharmaceuticals's Total Current Assets, to determine how well the company is positioned to perform in the future. Although Hepion Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Hepion Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hepion Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Hepion Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Hepion Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Current Assets17.5 M24 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Hepion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hepion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hepion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hepion Pharmaceuticals Stock:
Check out the analysis of Hepion Pharmaceuticals Correlation against competitors.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Hepion Stock analysis

When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Hepion Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.65)
Return On Assets
(0.71)
Return On Equity
(1.72)
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.